#biotechnology

#biotechnology

Imagine you're the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I'm not talking about the prospect of a coup or a revolution, or even a democratic election: I'm talking about the thing even more certain in life than taxes. I'm talking about death.

a little bit silly-sounding would probably stick in people's heads better

China's state broadcaster CCTV, which livestreamed the event to global media outlets, including The Associated Press and Reuters news agencies, reported that its coverage drew 1.9 billion views online and more than 400 million on television. As Putin and Xi approached Tiananmen Square's rostrum, Putin's interpreter was heard in Chinese saying: Biotechnology is continuously developing. Human organs can be continuously transplanted. The longer you live, the younger you become, and [you can] even achieve immortality. Xi, who was not on camera, responded: Some predict that in this century humans may live to 150 years old.

Flash forward to today, and the landscape couldn't look more different. For starters, thanks to accessible education and unfiltered reviews, social media has democratized the industry. Niche names now rival (and often replace) the big players, formulas have gotten cleaner and more sustainable, and new formats - lotions, solids, and more - share shelf space with traditional spritzes and sprays.

There was a time when nothing in cinema was more frightening than a xenomorph. HR Giger's nightmarish biomechanical hellspawn, dripping with fluids and Freudian discharge, was the gruesome, undisputed apex predator of movie monsters. It burst from your chest; it dissolved your face with acid; it splintered your ribcage like a pinata filled with blood and screams. It was unstoppable, unknowable, the kind of thing you'd expect to find at the bottom of your dishwasher after leaving it closed for 36 centuries.

Since late 2022, the local biotech industry has experienced a continuous wave of layoffs due to failed trials, slashed drug pipelines, and stock price collapses.

Cornell has secured a 10-year, $10 million grant renewal to continue work aimed at spurring economic impact and job growth through applied research, development and commercialization of breakthrough technologies.

Scientists fear that the restrictions on Covid mRNA vaccines may impede progress in mRNA cancer research, potentially stalling advancements in treating aggressive cancers such as pancreatic cancer.

"We're able to transform a prolific environmental and societal waste into such a globally important medication in a way that's completely impossible, using chemistry alone or using biology alone," says study coauthor Stephen Wallace, a chemical biotechnologist at the University of Edinburgh in Scotland.

Many medical breakthroughs, whose benefits are easy for anyone to grasp, begin with scientists asking questions that are difficult for most people to understand.

While big names get the spotlight, smaller healthcare stocks often hold the most explosive upside, with potential for significant gains in the coming years.

"In mathematics, physics and chemistry, Chinese funding has caught up with that of the United States. But the number of biomedical scientists supported by research funding in China is lower than in the United States."

If there are fewer medical diagnostics there will be fewer medical devices and treatments. Real innovation is a function of risk and reward in a mathematical sense.

Penny stocks, despite their appeal due to low prices and high potential gains, carry significant risks, including volatility and susceptibility to manipulation.

"If the science we create isn't reaching patients, what are we doing?"

Considering the wide range of possible applications, it is surprising that there have been no studies to date using CRISPR-Cas9 in spiders.

Typically, people think about robots as devices that you build with plastic and metal and the wires and software. But because fruit flies are so well understood, they can be treated as living robots.

We are impressed with the team's passion and the early commercial validation of its technology. Alongside HBG Ventures, CHECK24 Impact, and Rockstart, we are excited to support SenseUP's continued growth.

Regeneron is acquiring 23andMe for $256 million post-bankruptcy, aiming to support its mission while assuring customer privacy and data protection.

My first job after graduating with my MSc was as a research associate at the biotechnology company Serono. Going straight into a biotech company was a great career move.

The mosquitoes released in Djibouti are a vital tool in combating malaria, but their effectiveness needs to be complemented by existing prevention methods like nets and vaccines.

Pliant Therapeutics announced a 45% workforce reduction, equivalent to about 75 employees, to extend its cash runway after halting a critical Phase 2b trial over safety concerns.

Immunologist Jacob Glanville identified a unique opportunity to study the blood of Tim Friede, who gained immunity to snake venom after 18 years of exposure.

The cocktail combines two protective antibodies from Tim Friede’s blood and a small molecule venom inhibitor, paving the way for a universal antivenom.

Basic research conducted by America's universities is pivotal in fostering an entrepreneurial culture, evidenced by collaborations between academia and notable venture capitalists in technology and medicine.